Merck confirms FDA approves Keytruda combos with Padcev
Merck announced the U.S....
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
MRK: FDA Approves KEYTRUDA
MRK's KEYTRUDA and KEYTRUDA QLEX are approved by the FDA for first-line treatment of PD-L1+ advanced triple-negative breast cancer